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Validation of an analytical method is a necessary step in controlling the quality of 
quantitative analysis. Method validation is an established process which provides 
documentary evidence that a system fulfils its pre-defined specification, or shows 
that an analytical method is acceptable for its intended purpose. The purpose of the 
present study was to validate an SPE-LC-MS/MS method for the determination of 
17b-estradiol and estrone in surface water samples according to the requirements 
laid down in ISO 17025. The calibration curves, working ranges, recoveries, 
detection and quantification limits, trueness as well as repeatability were 
determined. The uncertainty budget was estimated following a top-down approach 
based on in-house validation data. For 17-estradiol, the expanded relative 
uncertainty was estimated as 16 and 15% at low and high concentration levels 
respectively, based on 15 replicate measurements on 5 days, and as 50 and 44% 
for a single measurement performed on a single day. For estrone, the expanded 
relative uncertainty was estimated as 13 and 12% at low and high concentration 
levels respectively, based on 15 replicate measurements on 5 days, and as 42 and 
38% for a single measurement performed on a single day.  




17-estradiol chemical structure: 
   
 





Chemical property data 
 17-Estradiol Estrone 
Formula C18H24O2  C18H22O2 
Molecular 
mass 
272.38g/mol 270.37 g/mol 








Steroid hormones are biologically active compounds; synthetised from cholesterol 
and secreted by the adrenal cortex, testes, ovaries and placenta in humans and 
animals.  
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Among them, estrogens, such as 17-estradiol and estrone, are predominantly 
female hormones that are important for maintaining the health of reproductive 
tissues, breasts, skin and brain.  
All humans as well as animals can excrete steroid hormones from their bodies, 
which end up in the environment through sewage discharge and animal waste 
disposal.  
Their feminisation effects in invertebrates and fish have been confirmed worldwide 
(Caldwell et al., 2008) 
In the first review of the list of priority substances (PS) under the European Water 
Framework Directive (WFD), the Commission’s legislative proposal introduced an 
environmental quality standard (EQS) for 17-estradiol in the aquatic environment.  
The annual average EQS value (AA-EQS) for 17-estradiol was set at 4x10-4 µg/l in 
inland surface waters (including rivers, lakes and related artificial or heavily 
modified water bodies), and at 8x10-5 µg/l in other (coastal) surface waters.  
No AA-EQS has been established for estrone, for which the predicted no-effect 
concentration (i.e.: PNEC) in fresh water is known to be 3.6x10-3 µg/l. 
Both compounds have been put on the newly introduced “watch list” mechanism to 
collect European Union-wide monitoring data (EU, 2013).  
The analytical method reported in this report is based on solid-phase extraction 
(SPE) using a universal reversed-phase sorbent (HLB: hydrophilic-lipophilic 
balance) followed by ultra-high-pressure liquid chromatography coupled to tandem 
mass spectrometry (UHPLC-MS/MS) analysis. The procedure has been fully 
characterised in terms of linearity, working range, selectivity, matrix effect, 
precision, repeatability, trueness and uncertainty. 
The objective of this method validation exercise is to contribute to the chemical 
analysis of natural estrogens in the aquatic environment in compliance with the first 
watch list exercise for the implementation of the Water Framework Directive 
(WFD). 
2 Materials and methods  
2.1 Chemicals  
2.1.1 Standards 
17-Estradiol, CAS 50-28-2, batch 10407, purity 98.5%, expiry date May 23, 2015, 
Dr Ehrenstorfer, LCG Standard S.r.l., Milan, Italy 
Estrone, CAS 53-16-7, batch SZE8123X, purity 99.3%, expiry date May 02, 2015, 
Sigma Aldrich, MO (USA). 
17-estradiol (3, 4 13C2, 99%), 100 µg/ml in acetonitrile, batch SDAB-007, purity > 
98%, expiry date May 21, 20120, CIL, MA (USA). 
 
2.1.2 Materials and reagents 
Ethyl acetate for trace analysis (Carlo Erba Reactifs-SDS). 
Methanol, code 701091.1612, (LC-MS) PAI, Panreac Quimica, Barcelona (Spain). 
MilliQ water obtained from a MilliQ water system, Millipore, Bedford, MA (USA). 
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Ammonium hydroxide, 28% in water, 99.99% metals basis, code 338818, Sigma 
Aldrich, Germany. 
OASIS HLB cartridges 6CC (0.2 g), code WAT106202, Waters, Milford, MA, USA. 
 
2.1.3 Reagent solutions 
Mobile phase A: 0.1% NH4OH  
a. Withdraw 0.385ml of ammonium hydroxide. 
b. Dilute to 1-l volume with water. 
Mobile phase B: methanol 
a. Degas in an ultrasonic bath for 20 seconds. 
 
UHPLC Autosampler strong washing solution 
a. Transfer 900 ml of water and 100 ml of methanol into a 1-l bottle. 
b. Mix and degas in an ultrasonic bath for 20 seconds. 
 
UHPLC Autosampler weak washing solution 
a. Transfer 100 ml of water and 900 ml of methanol into a 1-l bottle. 
b. Mix and degas in an ultrasonic bath for 20 seconds. 
 
UHPLC Seal washing solution 
a. Transfer 100 ml of methanol and 900 ml of water into a 1-l bottle. 
b. Mix and degas in an ultrasonic bath for 20 seconds. 
 
UHPLC-MS/MS Reconstituting solution for LC-MS/MS analysis 
a. Transfer 900 ml of mobile phase A into a 1-l bottle. 
b. Add 100 ml of mobile phase B and mix. 
 
2.1.4 Standard solutions 
17-estradiol stock standard solution (1 100 µg/ml) 
a. Accurately weigh approximately 11.1 mg of 17-estradiol in a 10-ml volumetric 
flask. 
b. Dissolve and dilute to volume with methanol and mix. 
 
Estrone stock standard solution (1 004 µg/ml) 
a. Accurately weigh approximately 10.04 mg of estrone in a 10-ml volumetric 
flask. 
b. Dissolve and dilute to volume with methanol and mix. 
 
17-estradiol and estrone working standard solution A (1 110 ng/ml, 1 004 ng/ml) 
   Page 10 of 37 
 
a. Withdraw 0.05 ml of 17-estradiol stock standard solution and 0.05 ml of 
estrone stock standard solution into a 50-ml volumetric flask. 
b. Dissolve and dilute to volume with methanol and mix. 
 
17-estradiol and estrone working standard solution B (1.11 and 1.004 ng/ml) 
a. Withdraw 0.05 ml of 17-estradiol working standard solution A and 0.05 ml of 
estrone working standard solution A into a 50-ml volumetric flask. 
b. Dissolve and dilute to volume with methanol and mix. 
 
Standard Solution A (17-estradiol 0.111 ng/ml; estrone 0.1004 ng/ml) 
a. Transfer 100 µl of working standard solution B into a 1-ml dark vial. 
b. Dilute to 1 ml with methanol and mix. 
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Standard Solution B (17-estradiol 0.555 ng/ml; estrone 0.502 ng/ml) 
a. Transfer 500 µl of working standard solution B into a 1-ml dark vial. 
b. Dilute to 1 ml with methanol and mix. 
 
Standard Solution C (17-estradiol 11.1 ng/ml; estrone 10.04 ng/ml) 
a. Transfer 10 µl of working standard solution A into a 1-ml dark vial. 
b. Dilute to 1 ml with methanol and mix. 
 
Standard Solution D (17-estradiol 55.5 ng/ml; estrone 50.2 ng/ml) 
a. Transfer 50 µl of working standard solution A into a 1-ml dark vial. 
b. Dilute to 1 ml with methanol and mix. 
 
Standard Solution E (17-estradiol 111 ng/ml; estrone 100.4 ng/ml) 
a. Transfer 100 µl of working standard solution A into a 1-ml dark vial. 
b. Dilute to 1 ml with methanol and mix. 
 
Standard Solution Low QC (17-estradiol 0.333 ng/ml; estrone 0.301 ng/ml) 
a. Transfer 300 µl of working standard solution B into a 1-ml dark vial. 
b. Dilute to 1 ml with methanol and mix. 
 
Standard Solution High QC (17-estradiol 99.9 ng/ml; estrone 90.4 ng/ml) 
c. Transfer 90 µl of working standard solution A into a 1-ml dark vial. 
d. Dilute to 1 ml with methanol and mix. 
 
2.1.5 Internal standard solutions 
Internal standard stock solution  
17-estradiol 13C2, 100 µg/ml in acetonitrile 
 
Internal standard working solution 1 (17-estradiol 13C2, 5 µg/ml) 
a. Transfer 250 µl of 17-estradiol 13C2 stock solution into a 5-ml volumetric flask. 
b. Dilute to 5 ml with methanol and mix. 
 
2.2 Apparatus 
2.2.1 Laboratory equipment 
Analytical balance:  Model AX204, Mettler-Toledo SpA 
Automatic pipettes:  Eppendorf Research (Milan, Italy) 
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Microsyringes:  Microliter Syringes, Hamilton (Reno, CA, USA) 
Autosampler vials for LC-MS: Micro-V vials target Dp clear, 1.5 ml, 12x22 mm 
National Scientific (Germany) 
Volumetric flasks:  Grade A various sizes, Duran® 
Volumetric pipettes:  Grade A various sizes, Duran® 
Dionex Autotrace AT280 automated SPE system (Thermo Scientific, Waltham, MA, 
USA) 
TurboVap II (Caliper Life Science, Mountain View, CA, USA) 
Vortex Genius, Ika, Staufen, Germany 
2.2.2 Instrumental equipment and conditions 
2.2.2.1  UHPLC equipment and conditions  
Pumps: Binary Solvent Manager, Model UPB, Waters (Milford, MA, USA) 
Autosampler: Sample Manager, Model UPA, Waters (Milford, MA, USA) 
Detector: QTRAP 5500, Applied Biosystems MDS SCIEX, (Foster City, CA, 
USA) equipped with Turbo V™ ion source 
Flow rate: 300 µl/min  
Injection volume: 5 µl 
Analytical 
column: 
BEH C18, 1.7 µm, 50 x 2.1 mm, Waters, (Milford, MA, USA) 
Mobile phase A: 0.1% ammonium hydroxide  
Mobile phase B: methanol 
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The chromatography was performed in gradient mode according to the following 
scheme: 
 
Time  A B Flow (ml/min) 
0 90 10 0.3 
0.5 80 20 0.3 
1 60 40 0.3 
5 20 80 0.3 
6 20 80 0.3 
6.5 90 10 0.3 
8 90 10 0.3 
Under these conditions, 17β-estradiol and estrone co-eluted at about 4.5 minutes. 
The run time was 8 minutes. 
2.2.2.2  QTRAP 5500 operative condition  
An AB Sciex QTRAP5500 mass spectrometer equipped with Turbo V™ ion source 
was used. The instrument was previously tuned and calibrated in electrospray mode 
using polypropylene glycol (PPG). Prior to analysis, all the specific parameters were 
optimised infusing a 1 µg/ml standard solution of analyte and internal standard 
(IS).  
The eluent from the column was introduced directly into the ion source. The rapid 
desolvation and vaporisation of the droplets minimises thermal decomposition and 
preserves their molecular identity. The data were collected using the software 
programme Analyst 1.6. 
All calculations were based on chromatographic peak area ratios for the multiple 
reaction monitoring (MRM) precursor-product ion transitions for analyte to the 
precursor-product ion transition of the internal standard. The general operating 
conditions were as follows: 
Scan Type:  Scheduled MRM 
Polarity:  Negative  
Ion Source:  Turbo Spray 
Resolution Q1:  Unit 
Resolution Q3:  Unit 
MR Pause:  5.0000 msec 
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 271>145 271>143 
17-Estradiol 
(271>145; 143) 
4.5 -83 -60 -78 
 269>145 269>143 
Estrone (269>145; 
143) 
4.5 -100 -53 -74- 
17-Estradiol 13C2 
(273>145) 
4.5 -215 -71 
 
Curtain gas (CUR):     25 
Collision gas (CAD):     Medium 
Temperature (TEM):     550 
Ion Transfer Voltage (IS):    -4 500. 
Entrance Potential (EP):   10.00 
Collision cell Exit Potential (CXP):  -11.00 
Ion Source gas 1 (GS1) :   55 
Ion Source gas 2 (GS2) :   45 
3 Experimental set up of method validation  
Different experiments were carried out for the characterisation of the developed 
procedure in terms of limit of detection and quantitation, linearity and working 
range, recovery, trueness, repeatability, intermediate precision and sample and 
extract stability. In our approach, a calibration curve and quality control samples 
(QCs) were freshly prepared in MilliQ water in triplicate for five different days. 
Some of the experiments were used in the evaluation of different parameters.  
The analyte / internal standard peak area ratios will be used as target parameters 
for quantitation. A weighted (1/c) least-square regression analysis of data was 
performed to determine the calibration curve parameters and the coefficient of 
determination (R2). 






X = analyte concentration 
Y = peak area ratio = 
areapeak  I.S.
areapeak    analyte 
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A = slope  
B = intercept. 
Analyst 1.6 software was used for data acquisition and data processing.  
Statistical calculations will be performed using Excel software. 
 
3.1 Calibration curve 
Calibration standards in MillliQ water (six different spiking levels, including a blank 
sample) covering the studied calibration range (0.11-111 ng/l for 17-estradiol and 
0.10-100.4 ng/l for estrone) were freshly prepared and processed on each day of 
validation. 
The relationship (goodness of fit) between peak area ratios of analyte / I.S. and 
concentrations in the investigated concentration range was assessed by the 
coefficient of determination (R2) and by the shape of the distribution of residuals 
around the horizontal axis. 
The acceptance criteria set for calibration curves were: 
 R2  0.9900 calculated over five calibration curves and  
 random dispersion of residuals around the horizontal axis, proving the 
pertinence of the linear regression model to interpret the data. 
3.1.1 Matrix effect 
A specific test for matrix effect was made by applying the standard addition method 
to typical test material.  
Surface waters (i.e. Lake Maggiore, Ispra Bay, (VA), Italy) were sampled and 
spiked in a way that provides the same final dilution as the normal procedure 
produces in MilliQ water. 
The range of addition encompassed the same range as the samples spiked in MilliQ 
water.  
Analysis of covariance (ANCOVA, Field et al., 2012) was first used to compare the 
calibration curves within each water type (i.e. MilliQ water and surface water) to 
check the stability over several days. Calibration curves were then compared within 
water types to assess whether a matrix effect exists. 
ANCOVA was applied to the following three cases: 
a. 5-day calibration curves for each compound in MilliQ water 
b. 2-day calibration curve per each compound in surface water 
c. 2 calibration curves per each compound measured in both MilliQ and surface 
water after establishing the stability over several days (cases a and b). 
ANCOVA was performed using the R software (R Core Team, 2014) with the 
following variables specifications:  
 Std the covariate variable = the concentration of the standard solution used 
to compute the calibration curve. Five concentration levels were used. 
 Computed, the dependent variable = the computed concentration of the 
compound obtained from the peak area ratio. 
 Day, the factor = the fixed factor which corresponds to the number of 
calibration days in cases a and b, and to the matrix type in case c. 
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An analysis of covariance was performed to establish whether all calibration curves 
obtained for each level of the factor have equal slopes and intercepts. This means 
verifying whether or not the factor has a significant effect on the dependent 
variable, “cleaned” by the effect of the covariate variable. 
Depending on the case, the factor can have two or five levels. In case a, the five 
levels are given by the five different days on which the calibration curves are 
determined in MilliQ water. In case b, the two levels are given by the two different 
days on which the two calibration curves are determined in surface water. In case 
c, the two levels correspond to the calibration curves determined in both MilliQ and 
surface water after having verified the day-to-day stability of calibration curves in 
each water type separately. 
3.2 Repeatability and intermediate precision 
Quality control samples (QCs) were freshly prepared in MilliQ water and analysed in 
triplicate during validation days at two spiking levels (0.33 and 99.9 ng/l for 17-
estradiol and 0.3 and 90.4 ng/l for estrone) for a total of 15 independent sample 
preparations. 
The acceptance criterion set for the relative standard deviation (RSD) of the 
repeatability and intermediate precision was 20% at both spiking levels.  
3.3 Limits of detection and quantification  
The limits of detection and quantification were estimated by analysing 12 and 15 
different blank samples for 17-estradiol and estrone, respectively. 
The mean value of blank samples (b) and the RSD served for LOD and LOQ 
estimation, were calculated in accordance with the following equations: 
LOD = b + 3SD 
LOQ = b + 10SD. 
3.4 Trueness 
Trueness was assessed by analysing three different QCs at two spiking levels (see 
3.2) on each day of validation, and by the application of the significance test (t-
test) at the 95% confident level.  
Considering that the QCs were spiked using aliquot withdrawals from the respective 
working standard solutions, the t test was applied on a total of five samples (as the 
average result of the triplicate quality controls analysed for each day of validation) 
and four degrees of freedom. The difference between the mean value of spiked 
MilliQ water samples and their nominal concentrations was evaluated according to 










where x is the mean value of n samples with standard deviation SD, and µ is the 
nominal concentration.  
3.5 Recovery 
Recovery was evaluated by extracting and analysing in triplicate 1-litre MilliQ water 
samples spiked, before extraction, with native analytes only. The internal standard 
was then added to the extracts at the end of the sample preparation with the aim 
of allowing for the estimation of analytes lost during processing. 
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The recovery was evaluated by comparing the ratios of analyte/IS in spiked 
samples to the same ratios obtained by analysing a standard solution containing 
native compounds and the labelled solution at the same concentration levels, not 
subject to any handling.  
The spiking level was 10 ng/l for both 17-estradiol and estrone. 
3.6 Stability  
3.6.1 Stability of extract  
Three extracts of QCs at each spiking level were re-injected after 2, 7 and 14 days 
of storage at 4°C in the dark. In order to be considered stable, the concentrations 
of re-injected samples have to fall within about twice the standard deviations of the 
concentration of QCs used for the repeatability study. 
4 Preparation of calibration standards and water 
samples  
4.1 Calibration standards and Quality Control samples (QCs) 
a. Fill 1-l glass bottle with 1 l MilliQ water. 























A 0.111 0.111 0.1004 0.1004 50 
B 0.555 0.555 0.502 0.502 50 
C 11.1 11.1 10.04 10.04 50 
D 55.5 55.5 50.2 50.2 50 
E 111 111 100.4 100.4 50 
Low QC 0.333 0.333 0.301 0.301 50 
High QC 99.9 99.9 90.4 90.4 50 
4.2 Water sample extraction  
a. Add 10 µl of 17-estradiol 13C2 working solution to 1 l water standard and QCs 
b. Shake the water sample 
c. Condition SPE OASIS HLB cartridge with 10 ml of ethyl acetate 
d. Condition SPE cartridge with 10 ml of methanol 
e. Condition SPE cartridge with 10 ml of water 
f. Load water samples at 10 ml/minute 
g. Dry the sorbent under nitrogen for 30 minutes 
h. Elute the sample with 10 ml ethyl acetate at 5 ml/minute 
i. Reconstitute with 0.5 ml of reconstituting solution for LC-MS/MS analysis. 
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5 Validation procedure and results 
5.1 Selectivity 
For the identification of 17-estradiol and estrone, two multiple reaction monitoring 
(MRM) transitions between the precursor ion and the two most abundant fragment 
ions were monitored. The first was used for quantification purposes, whereas the 
second (“qualifier”) was used to confirm the presence of the target compound in 
the sample. The quantified analyte was identified by comparing the retention time 
of the corresponding standard and the isotopic ratio between two ions recorded 
(±30%) in the standard and water samples. 
The selected mass transitions used for quantification and confirmation were 
respectively 271 > 145, 143 for 17-estradiol, 269>145, 143 for estrone, and 271 
> 145, 147 for 17-estradiol 13C2. 
 
5.2 Limit of detection (LOD) and limit of quantification (LOQ) 
Limits of detection and quantification were estimated by analysing blank samples.  
A typical blank chromatogram is depicted in Figure 1. The left and right panels 
show instrumental signals for the quantification of MRM transitions of analyte and 
internal standard, respectively.  
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Figure 1 – Chromatograms for 17-estradiol and estrone in blank sample 
   
 
 
The mean values of the blank samples (b) and standard deviation (SD) were 
calculated using the data resulting from these experiments. The LOD and LOQ were 
estimated according to the formula reported in 3.3. 
The results of the LOD and LOQ estimation are shown in Error! Reference source 
not found.. 
 
Table 1 - LOD and LOQ values 









12 0.03 0.08 
Estrone 15 0.06 0.1 
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5.3 Linearity study 
The linearity of the whole SPE-LC-MS-MS procedure was studied in the 
concentration range 0.11-111 ng/l for 17-estradiol and in the range of 0.01-100.4 
ng/l for estrone. 
In order to verify the linearity of the calibration curve, a blank sample spiked only 
with labelled IS and five spiked MilliQ water samples (i.e. at 0.11, 0.55, 11.1, 55.5 
and 111 ng/l for 17-estradiol and at 0.10 0.5, 10.0, 50.2 and 100.4 ng/l for 
estrone) were extracted and analysed in three replicates on five different days. The 
calibration curves are illustrated in Figure 2a for 17β-estradiol and in Figure 2b for 
estrone. 
Figure 2 – Calibration curves for 17-estradiol 
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Figure 3 – Calibration curves for estrone 
 
As reported in Table 2, the mean coefficient of determination (R2) values, calculated 
over five calibration curves, were ≥0.998, with an RSD of 14.9% and ≥0.998, with 
an RSD of 8.0% for 17-estradiol and estrone, respectively. 
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Table 2 
Table 3 - Coefficient of determination (R2) values for calibration curves on different days 
Validation Day/Analyte R2 R2 
 17-Estradiol Estrone 
1 0.9997 0.99963 
2 0.9963 0.99834 
3 0.9993 0.9994 
4 0.9998 0.99928 
5 0.9995 0.99775 
Average 0.9989 0.9989 
RSD (%) 14.9 8.0 
 
The study of the distribution of residuals revealed shapes randomly dispersed 
around the horizontal axis, proving the pertinence of the linear regression model for 
interpreting the data. The residual plots are shown in Figure 4 and Figure 5. 
Figure 4 – Residual plots for 17-Estradiol 
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Figure 5 – Residual plots for Estrone 
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5.4 Matrix Effect 
For a detailed statistical analysis of inputs and outputs, please refer to Annex 1.  
A summary of the results is reported in the following sub-sections.  
5.4.1 Verification of the ANCOVA assumption 
Prior to the computation of the ANCOVA, the abovementioned assumptions must be 
verified for each of the two analysed compounds. All computations were carried out 
using R software (R Core Team, 2014). 
5.4.1.1 Independence 
This assumption implies that the covariate and any independent variables must be 
independent: it is verified by running an ANOVA with the covariate as the outcome 
and any independent variables (factors) as predictors to check that the covariate 
does not differ significantly across levels of these variables.  
Since concentration levels of the standard solution (the covariate) were equal over 
time (cases a and b) and among matrices (case c), the p-value was 1 for all the 
cases and the hypothesis of independence was accepted. 
5.4.1.2 Normality 
This assumption could be checked by examining the residual plots from the fitted 
model for evidence of non-normality.  
If the assumptions are satisfied, residuals should vary randomly around zero and 
the spread of the residuals should be about the same throughout the plot, with no 
systematic patterns. For the cases studied, the residuals did not suggest a time or 
matrix trend and the assumption of normality was accepted. 
5.4.1.3 Homogeneity of variance 
Levene’s test was used to determine whether the variance in the outcome variable 
varies across groups.  
For all of the tested cases, Levene’s test results were non-significant, with p-values 
ranging between 0.9975 and 1. This means that the variances are very similar and 
the hypothesis of homogeneity of variances was accepted. 
5.4.1.4 Linearity 
The assumption of linearity was checked by looking at the individual plots of Y vs. X 
for each factor. No outliers should be identified. 
5.4.1.5 Homogeneity of regression slopes 
This assumption was verified by plotting a scatterplot for each experimental 
condition (factor) with the covariate on one axis and the outcome on the other.  
The homogeneity of regression slopes is accepted if slopes are similar across 
groups.  
From the scatterplots (plotted for the linearity assumption) it was clear that slopes 
are comparable.  
5.4.2  ANCOVA Results 
All statistical analyses were performed using R software (R Core Team, 2014). 
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5.4.2.1 Estrone: case a. – MilliQ water 
The ANCOVA model was performed specifying five different slopes and five different 
intercepts (one per day). The model estimated 10 parameters from the data: five 
intercepts and five slopes.  
Based on the output of the ANCOVA computation, the hypothesis of equal slopes 
(p-value>>0.05) and the hypothesis of equal intercepts (p-value=0.24) of 
regression lines were both accepted. It was therefore concluded that the day on 
which the calibration was computed did not influence the output variable 
(concentration of the analyte). 
5.4.2.2 Estrone: case b. – Surface water 
Here, the ANCOVA model was simpler, with only two different slopes and intercepts 
to compare. The model estimated four parameters from the data: two intercepts 
and two slopes.  
From ANCOVA results, choosing a level of confidence of 95%, the hypothesis of 
equal slopes and intercepts between the regression lines was accepted (P-level = 
0.07 for slopes, P-level = 0.93 for intercepts). 
5.4.2.3 Estrone: case c. – Surface vs. MilliQ water 
After testing the daily comparability of calibration curves in the MilliQ and surface 
water separately, it was possible to compare the calibration curves between the two 
matrices. In this case, the ANCOVA would give us information about the effect of 
the matrix type.  
The calibration curve of the first day for each matrix type was taken for 
computatiing the ANCOVA. 
Based on the results, the hypothesis of equal slope between the regression lines 
was accepted with a 95% confidence level (p-level=0.238). Moreover, the p-value 
for the hypothesis of equal intercepts between calibration curves was 0.802, 
indicating the acceptance of the null hypothesis. 
The two calibration curves derived from the analysis of Estrone in surface and MilliQ 
waters can be assumed to be coincident at a level of confidence of 95%.  
This implies that the matrix type has no significant effect on calibration curves for 
the considered analyte. 
5.4.2.4 17-estradiol: case a. MilliQ water 
For case a,  the hypothesis of equal slopes between the five calibration curves (p-
value=0.378) and the hypothesis of equal intercepts (p-value=1.0) were both 
accepted based on the ANCOVA output,. 
This indicated that there is no significant difference between the slopes and the 
intercepts of the calibration curves at a level of confidence of 95%. 
5.4.2.5 17-estradiol: case b. Surface water 
For the interaction term (Day x Std), the probability value P higher is 0.942, 
indicating that there was no significant difference between the slopes of the 
calibration curves.  
Moreover, the p-values for the effect of the day parameter was 0.867, indicating 
equal intercepts between calibration curves. 
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5.4.2.6 17-estradiol: case c. Surface vs MilliQ water 
After testing the daily comparability of calibration curves in the MilliQ and surface w
aters separately, it was possible to compare the calibration curves between the two
 matrices. 
Even in this case, there was no significant difference between the slopes of the 
calibration curves (p-value=0.69). Moreover, a p-value of 0.94 indicates equality of 
the intercepts between calibration curves. This implies that the matrix type had no 
significant effect on the calibration curves for the considered analyte. 
5.5 Working Range 
The working range, defined as the range of concentrations for which the chosen 
calibration curve is valid, was defined by the limits of quantification and highest 
point in the respective calibration curve. Error! Reference source not found. 
summarises the working range established for the procedure for 17-estradiol and 
estrone, respectively. 
Table 4 - Working range of the analytical method 





Fifteen QCs at low and high concentration levels (i.e. about 0.3 and 90 ng/l) were 
extracted and analysed.  
In order to demonstrate the truthfulness of the null hypothesis (H0: the analytical 
method is not subject to systematic error), average back-calculated concentrations 
of three replicates per concentration level on five days of validation were 
considered and evaluated.  
As reported in Tables 4 and 5, the t-values were found to be lower than the critical 
values for the target analytes at the studied concentration levels, demonstrating 
the absence of evidence of systematic errors in the quantification of the analytes. 
 


























0.34 5 4 0.33 0.04 0.57 2.78 OK 
105.74 5 4 99.9 11.7 1.12 2.78 OK 
Table 6 - Results of the trueness study for estrone at different concentration levels 

























0.33 5 4 0.301 0.035 1.85 2.78 OK 
98.5 5 4 90.4 9.4 1.93 2.78 OK 
 
5.7 Recovery 
The results of the recovery experiments, carried out according to section 3.5, are 
reported in Table 6. 
Table 7 - Recovery 
Analyte Spike Level  
(ng/l) 
Mean Recovery  
(%) (n=3) 
SD (ng/l) RSD (%) 
17-Estradiol 10 67.5 6.8 10 
Estrone 10 70.7 7.0 9.9 
 
5.8 Repeatability and intermediate precision 
For repeatability and intermediate precision, QCs at two concentration levels were 
tested on five different days. For each sample, three replicate injections were 
made. Using a one-way ANOVA, the results were obtained as shown in Table 7 and 
Table 8 for 17-estradiol and estrone, respectively. 
Table 8 – RSDs of repeatability and intermediate precision for 17-estradiol 
Concentration 
level 
Relative standard deviation (RSDRep) of 
Repeatability measurements 
Relative standard deviation (RSDIp) of 
Intermediate precision measurements 
Low 21.7 12.2 
High 19.1 10.9 
Table 9 – RSDs of repeatability and intermediate precision for estrone 
Concentration 
level 
Relative standard deviation (RSDRep) of 
Repeatability measurements 
Relative standard deviation (RSDIp) of 
Intermediate precision measurements 
Low 18.2 10.0 
High 16.5 9.4 
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5.9 Stability of extract 
Graphical representations of the stability of extracts are given in Figure 6 and 
Figure 7.  
Since the concentrations evaluated by re-injections after storage for 2, 7 and 14 
days at 4°C in the dark fall within about twice the standard deviations of the 
concentration of QCs used for repeatability evaluation, the extracts could be 
considered as being stable in the studied conditions. 
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5.10 Uncertainty estimation 
The estimation of measurement uncertainty was carried out following a top-down 
approach based on in-house validation data. The data derived from the validation of 
the method include the sample preparation, standard dilution, and chromatographic 
and mass spectrometric detection variability. This approach takes account of the 
relative standard deviation of repeatability, intermediate precision and trueness 
measurements. The uncertainty of prepared standard stock solutions is also 
considered, as another source of uncertainty.  










       222Re
2
StdIppTness uuuukU   
where: 
 
U is the expanded relative uncertainty,  
k is the coverage factor (k=2), 
uTnessuTness is the relative standard uncertainty of trueness estimation,  
uRep is the relative standard uncertainty of repeatability, 
uIpuIpuIp is the relative  standard uncertainty of intermediate precision, and  
uStd is the relative standard uncertainty related to calibration standards including 
weighing, purity and dilution contributions.  
 
5.10.1 Uncertainty of trueness 
uTness is the standard relative uncertainty associated with the trueness, and has 
been calculated from the standard deviation (SD) of the mean of QCs used for 















C is the average result of the QCs analyses,  
n is the number of QCs that have been analysed. 
 
5.10.2 Uncertainty of repeatability and intermediate precision  
uRepuRep and  uIp are the standard relative uncertainties related to repeatability and 
intermediate precision measurements, respectively. Individual contributions are 
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RSDRep standard deviation of repeatability measurements  
RSDIp standard deviation of intermediate precision measurements 
nRep number of total replicates for repeatability measurements 
ndays number of days for intermediate precision measurements. 
 
5.10.3 Uncertainty of standard 
u Std  is the standard relative uncertainty associated with 17β-estradiol, estrone 










in case of 17β-estradiol and as follows  
       2222 2 BalanceSyringeFlaskEstroneStd uuuuu   
in the case of estrone, where: 
For 17-Estradiol, the Manufacturer’s Certificate of Analysis reports the expanded 
combined uncertainty U17-Estradiol at 95% confidence level to be equal to 0.5%.  
Consequently:  
u17-Estradiol=U17-Estradiol/2 = 0.3. 
For Estrone, the Manufacturer’s Certificate of Analysis reports the expanded 
combined uncertainty UEstrone for a single measurement at 95% confidence level 
with n=6 to be equal to 0.5%.  
Consequently, the relative uncertainty is 0.2, according to the following formula:  
UEstrone =UEstrone/2.45 = 0.2. 
uFlask is the uncertainty related to the volumetric flask. The tolerance of the class A 
10-ml volumetric flask (given by the manufacturer) is set to 0.04 ml. As this value 
is not correlated with a confidence level or distribution information, a rectangular 
distribution is assumed. For the uncertainty estimation, the relative tolerance value 
(i.e. 0.4%) must by divided by 3 √3, giving a value of 0.231 for uFlask. 
uSyringe is the uncertainty related to the withdrawal of the standard solution using a 
1 000-µl Hamilton syringe. As these syringes are manufactured to be accurate 
within ± 1% of the nominal value and this value is not correlated with a confidence 
level or distribution information, a rectangular distribution is assumed. For the 
uncertainty estimation, the relative uncertainty (i.e. 1 ml/1 000 ml*100=0.1%) 
must by divided by√3 3 , giving a value for uSyringe equal to 0.058. 
uBalance is the contribution from the weight of standards, and it is due to the 
linearity uncertainty of the balance from the Calibration Certificate. From balance 
linearity (± 0.03 mg), a rectangular distribution is assumed to obtain a standard 
uncertainty; this contribution is considered twice, once for the tare and once for the 
gross weight. According to this approach, the uBalance as RSD % is: 























As the repeatability and trueness of the measurement were estimated for two 
different concentration levels, the uncertainty can also be estimated separately for 
low and high concentration levels. 
 
5.11 Final uncertainty budget  
Considering the data for 17-Estradiol, the uncertainty contribution from the 
repeatability assessment was 5.6% and 4.9% at low and high concentration levels 
respectively. The uncertainty contribution from intermediate precision was 5.5% 
and 4.9% at low and high concentration levels respectively. The uncertainty 
contribution from standard preparation was around 1%.  
The expanded relative uncertainty was estimated a 16% and 15% at low and high 
concentration levels respectively, based on 15 replicate measurements on 5 days, 
and as 50% and 44% for a single measurement performed on a single day. 
Considering the data for Estrone, the uncertainty contribution from the repeatability 
assessment was 4.7% and 4.3% at low and high concentration levels respectively. 
The uncertainty contribution from intermediate precision was 4.5% and 4.2% at 
low and high concentration levels respectively. The uncertainty contribution from 
standard preparation was around 1%.  
The expanded relative uncertainty was estimated as 13% and 12% at low and high 
concentration levels respectively, based on 15 replicate measurements on 5 days, 
and as 42% and 38% for a single measurement performed on a single day. 
The detailed uncertainty budget and results of the uncertainty estimations are 
reported in Table 9. 
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Table 10 - Uncertainty budget and estimated uncertainty of measurements 
Estimated uncertainty Values   

















uTness (%) 0.1 2.1 0.1 1..5 
uRep (%) 5.6 4.9 4.7 4.3 
uIp (%) 5.5 4.9 4.5 4.2 




(U, %) (k=2), 
(n1=15, n2=5) 




(U, %) (k=2), 
(n1=1, n2=1) 
50 44 42 38 
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List of Abbreviations and Symbols 
Throughout this report, the following abbreviations and symbols are used: 
 
ANOVA Analysis of Variance 
ANCOVA Analysis of Covariance 
CAD Collision Gas  
CUR  Curtain Gas 
CRM Certified reference material 
CXP Collision Cell Exit Potential 
DG Directorate-General 
EC European Commission 
EP Entrance Potential 
EU European Union 
GS1 Ion Source gas 1 
GS2 Ion Source gas 2 
HLB Hydrophilic-lipophilic balance 
IES Institute for Environment and 
Sustainability 
IS Internal standard/Ion Transfer 
voltage 
ISO International Organization for 
Standardization 
 
JRC Joint Research Centre 
LC Liquid chromatography 
LOD Limit of detection 
LOQ Limit of quantification 
MRM Multiple reaction monitoring 
MS Mass spectrometry 
PNEC Predicted no effect concentration 
PPG Polypropylene glycol 
PS Priority substances 
QC  Quality control sample 
R2 Coefficient of determination 
RSD Relative standard deviation 
SD Standard deviation 
SPE Solid-phase extraction 
TEM Temperature 
UHPLC Ultra-high-pressure liquid 
chromatography 
WFD Water Framework Directive 
 
 
Chemical elements are identified by their respective symbols as defined by the 
International Union of Pure and Applied Chemistry (IUPAC)  
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1. Introduction:  
In the determination of Estrone and 17Estradiol in water samples, calibration 
curves prepared in MilliQ water were compared with those prepared in surface 
water. The comparison would indicate whether or not a significant matrix effect 
occurs for the selected analytes. 
For this purpose, five calibration curves in MilliQ water and two calibration curves in 
surface water were determined on different days. Analysis of covariance (ANCOVA) 
was first used to compare the calibration curve within each water type to check the 
stability over several days. Calibrations were then compared between water types 
to assess whether a matrix effect exists. 
The ANCOVA is a statistical tool that can be used to compare regression curves 
(slopes and intercepts). The ANCOVA is an extension of the analysis of variance 
(ANOVA) that provides a means of statistically controlling the (linear) effect of one 
or more continuous variables that are not part of the main experimental 
manipulation but have an influence on the dependent variable (Field et al., 2012). 
These variables are called covariates and should be measured on an interval or 
ratio scale. A one-way ANCOVA evaluates whether population averages of the 
dependent variable are the same across all levels of a factor (independent 
variable), adjusting for differences in the covariate. The factor divides individuals 
into two or more groups or levels, while the covariate and the dependent variable 
differentiate individuals based on quantitative dimensions. The one-way ANCOVA is 
used to analyse data from several types of studies, including studies that 
investigate the differences among calibration curves in order to check their stability 
(González et al., 2004), evaluate the existence of matrix effects (Wang et al., 
2013), and to compare different measurement procedures (de Pinho and Silvério, 
2012). 
2. Statistics  
2.1. Assumptions 
ANCOVA makes the same assumptions as ANOVA plus two considerations (points 1 
and 5): 
1. Independence: the covariate variable is independent of the groups (i.e. the covariant 
and independent variables are independent); 
2. Normality: the residuals must be normally distributed around the regression line for 
each group; 
3. Homogeneity of variance (homoscedasticity):  the variance must be equal for both 
groups around their respective regression lines; 
4. Linearity: the relationship between the dependent variable (y) and the covariate (x) is 
linear for each factor; 
5. Homogeneity of regression slopes: the regression lines for these individual factors are 
assumed to be parallel (they have the same slope). 
2.2. Problem under analysis 
ANCOVA was applied in order to compare slopes and intercepts obtained for the 
following three cases: 
a. Five-day calibration curves for compounds analysed in MilliQ water; 
b. Two-day calibration curves for compounds measured in Surface water; 
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c. Two calibration curves for compounds measured in both MilliQ and Surface water 
after accepting the stability over several days (cases a and b). 
All three cases were applied for the determination of Estrone and 17-Estradiol. 
ANCOVA was performed using the R software (R Core Team, 2014) with the 
following variables specifications: 
- Std, the covariate variable = the concentration of the standard solution used to 
compute the calibration curve. Five concentration levels were users. 
- Computed, the dependent variable = the computed concentration of the compound 
obtained from the peak area 
- Day, the factor = the fixed factor which corresponds to the calibration day in cases a 
and b, and to the matrix type for case c. 
The analysis of covariance was performed to establish whether, for each level of the 
factor, all calibration curves have equal slopes and intercepts. This means verifying 
whether or not the factor has a significant effect on the dependent variable, 
“cleaned” by the effect of the covariate variable. 
Depending on the case, the factor can have two or five levels. In case a, the five 
levels are given by the five different days on which the calibration curves are 
determined in MilliQ water. In case b, the two levels are the two calibration curves 
determined in surface water. In case c, the two levels correspond to the calibration 
curves determined in both MilliQ and surface water after having verified the day-to-
day stability of calibration curves in each water type separately. 
Null hypotheses 
The first null hypothesis of ANCOVA is that the slopes of the regression lines are all 
equal; in other words, the regression lines are parallel to each other. Once the null 
hypothesis that the regression lines are parallel is accepted, it is possible to test for 
the second null hypothesis: the intercepts of the regression lines are all the same. 
Pre-analysis:  
Five concentrations of the standard solution were analysed in three replicates. To 
conduct the ANCOVA analysis, the average values at each concentration level were 
computed and used. 
3. Procedure 
3.1. Verification of the ANOVA assumption 
Prior to the computation of the ANCOVA, the abovementioned assumptions must be 
verified for each case of the two analysed compounds. 
1. Independence 
This assumption requires that the covariate and any independent variables are 
independent: it is verified by running an ANOVA with the covariate as the outcome 
and any independent variables (factors) as predictors to check that the covariate 
does not differ significantly across different levels of these variables. The R code, 
which is applied to each case and for the two compounds separately, is the 
following: 
> independence<-aov(Std~Day, Edata) 
> summary(independence) 
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The results are summarised in the following tables, where the R output is given separ
ately for each compound: 
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Case Estrone: R output 
  Df Sum Sq Mean Sq F Value Pr(>F) 
a Day 4 0 0 0 1 
 Residual 25 41554 1662   
b Day 1 0 0 0 1 
 Residual 10 16622 1662   
c Day 1 0 0 0 1 
 Residual 10 16622 1662   
 
Case 17-Estradiol: R output 
  Df Sum Sq Mean Sq F Valiue Pr(>F) 
a Day 4 0 0 0 1 
 Residual 25 51142 2046   
b Day 1 0 0 0 1 
 Residual 10 20457 2046   
c Day 1 0 0 0 1 
 Residual 10 20457 2046   
 
Since concentration levels of the standard solution (the covariate) are equal over 
the different timespans (cases a and b) and matrices (case c), the p-value is 1 for 
all the cases and the hypothesis of independence is accepted. 
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3.2.  Normality 
This assumption can be checked by examining the residual plots from the fitted 
model for evidence of non-normality.  
 
Estrone: case a 
 
Estrone: case b 
 
 
Estrone: case c 
 
 
17βEstradiol: case a 
 
17β-Estradiol: case b 
 
17β-Estradiol: case c 
 
If the assumptions are met, residuals should vary randomly around zero and the 
spread of the residuals should be about the same throughout the plot, with no 
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systematic patterns. For these cases, the residuals do not suggest a time trend and 
the assumption of normality is accepted. 
 
3.3. Homogeneity of variance 
Levene’s test is used to determine whether the variance in the outcome variable 
varies across groups. The R code is the following: 
> leveneTest(Computed~Day, Edata) 
 
R output of Levene’s test is given in the following tables: 
 
Case  Estrone: R output 
  Levene’s test for Homogeneity of Variance (center = median) 
a  Df F value  Pr(>F) 
 group 4 0 1 
 25    
b  Df F value  Pr(>F) 
 group 1 0 0.9994 
 10    
c     
 Group    
 10 1 0 0.9988 
 
 
Case  17-Estradiol: R output 
  Levene’s test for Homogeneity of Variance (center = median) 
a  Df F value  Pr(>F) 
 group 4 0 1 
 25    
b  Df F value  Pr(>F) 
 group 1 0 0.9975 
 10    
c  Df F value  Pr(>F) 
 group 1 0 0.9996 
 10    
 
The output shows that Levene’s test is non-significant for all cases, with p-values 
ranging between 0.9975 and 1. This means that the variances are very similar and 
the hypothesis of homogeneity of variances is accepted. 
3.4. Linearity 
The assumption of linearity is checked by looking at the individual plots of Y vs. X 
for each factor. No outliers should occur. 






























Estrone: MilliQ water curves
Day 1 Day 2 Day 3 Day 4
Day 5 Linear (Day 1) Linear (Day 2) Linear (Day 3)


























Estrone: Surface water curves
Day 1 Day 2
Linear (Day 1) Linear (Day 2)





3.5. Homogeneity of regression slopes 
This assumption is verified plotting a scatterplot for each experimental condition 
(factor) with the covariate on one axis and the outcome on the other. The 
regression line for each of these scatterplots is then calculated, and the 
homogeneity of regression slopes is accepted if slopes are similar across groups. 
From the scatterplots (plotted for the linearity assumption) ,it is clear that slopes 



























17-β Estradiol: MilliQ water curves
Day 1 Day 2 Day 3 Day 4
Day 5 Linear (Day 1) Linear (Day 2) Linear (Day 3)



























17-β Estradiol: Surface water curves
Day 1 Day 2
Linear (Day 1) Linear (Day 2)
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4. Results 
4.1. Estrone: case a. – MilliQ water 
In R, the ANCOVA model with five different slopes and five different intercepts (one 
per day) is specified using the following formatting: 
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> model_1<-lm(Computed~Day*Std, Edata) 
> summary(model) 
 
The R output is the following: 
Call: 
lm(formula = Computed ~ Day * Std, data = Edata) 
 
 
Coefficients:     
 Estimate Std. Error T value  Pr(>|t|) 
(Intercept) -0.04917 0.65659   -0.075     0.941     
DayDay2  -0.56464     0.92856   -0.608     0.550     
DayDay3 -0.47042     0.92856   -0.507     0.618     
DayDay4 0.19961     0.92856    0.215     0.832     
DayDay5 0.50028     0.92856    0.539     0.596     
Std 1.00558     0.01432   70.240    <2e-16 *** 
DayDay2:Std 0.02242     0.02025    1.107     0.281     
DayDay3:Std 0.01767     0.02025    0.873     0.393     
DayDay4:Std -0.00829     0.02025   -0.409     0.687     
DayDay5:Std -0.01943     0.02025   -0.960     0.349     
     
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 1.305 on 20 degrees of freedom 
Multiple R-squared:   0.9992, 
Adjusted R-squared:   0.9988  
F-statistic:   2755 on 9 and 20 DF,   
p-value:  < 2.2e-16 
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The model estimated 10 parameters from the data (10 rows in the R output): five 
intercepts and five slopes. The first day (day was the unit used as factor) is used as 
a baseline against which to compare the other four days. 
The coefficients -0.04917 (Intercept) and 1.00558 (Std) represent the intercept 
and the slope of the regression line for day 1. For the second day, the intercept and 
the slope are given by the sum, respectively, of the first and second quantities (-
0.04917 + -0.56464 = -0.61381) and the sum of the sixth and seventh quantities 
(1.00558+0.02242 =1.028). The other days’ regression parameters can be 
computed in the same way by summing the proper rows. 
The last column on the right indicates the parameter values which are significantly 
different from zero when compared with day 1. The table shows that intercepts 
(first five rows) and slopes (last five rows) do not differ significantly from day 1 at a 
level of significance of 5%. However, this model compares, using a t-test, the 
slopes and the intercepts among days only with the slope and intercept for day 1. 
To test the hypothesis of equal slopes of regression lines for several different days, 
the complete model obtained with the interaction must be compared with the model 
for which the parallelism hypothesis is considered valid. The model with equal slope 
is given by: 
model_2 <- lm(Computed ~ Day + Std, Edata) 
 
and the comparison is obtained with the R code: 
 
anova(model_1, model_2) 
The output of the ANOVA command is: 
Analysis of Variance Table 
 
Model 1:   Computed ~ Day * Std 
Model 2:  Computed ~ Day + Std 
Res. Df RSS  
Df Sum of Sq F Pr(>F) 
1 20 34.067 
    
2 24 44.294 
-4 -10.27 1.501 0.2397 
 
From the output, the p-value from the F test is higher than 0.05 (Pr=0.2397) and 
the null hypothesis of equal slopes between the 5 regression lines is therefore 
accepted. At this point it is possible to test the equality of the intercepts. This is 
done by comparing the previous model (equal slopes) with the model which 
assumes equal regression lines (equal slopes and equal intercepts). 
Model_3 <- lm(Computed ~ Std, Edata) 
anova(model_2, model_3) 
 
The output is: 
Analysis of Variance Table 
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Model 1:   Computed ~ Day * Std 
Model 2:  Computed ~ Day + Std 
Res. Df RSS  Df Sum of Sq F Pr(>F) 
1 24 44.294     
2 28 44.308 -4 -0.0135 0.0018 1 
 
 
Based on the results, the hypothesis of equals regression lines (Pr>0.05) is 
accepted, which implies that the day on which the calibration is computed does not 
influence the output variable (concentration of the analyte). 
The same results can be obtained by another R command which results in an 
ANOVA table with the summary parameters: 
> model_B<-aov(Computed~Day*Std, Edata) 
> summary(model_B) 
 
 Df Sum Sq Mean Sq F value Pr(>F) 
Day 4 0 0 0.002 1 
Std. 1 42226 42226 24789.509 <2e-16*** 
Day:Std. 4 10 3 1.501 0.24 
Residual 20 34 2   
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
The F values and the corresponding probability values for the interaction term 
(Day:Std) and for the intercept (Day) are the same, as found in the previous 
computations taken separately. Again, this indicates that there is no significant 
difference between the slopes and the intercepts of the calibration curves, at a level 
of confidence of 95%. 
4.2. Estrone: case b. – Surface water 
It is easier to apply the ANCOVA model to case b, which has only two different 
slopes and intercepts to compare. The model is specified using the following 
formula: 
> model_1<-lm(Computed~Day*Std, Edata) 
> summary(model) 
 
 22/11/2016  Page XIV of XIX 
 
The output of the ANCOVA is the following: 
Call: 
lm(formula = Computed ~ Day * Analyte, data = Edata) 
 
Residuals:     
Min 1Q Median 3Q Max 
-0.26151 -0.09115 0.01426 0.11512 0.31967 
 
Coefficients:     
 Estimate Std. Error T value  Pr(>|t|) 
(Intercept) 0.055914 0.101366 0.552 0.5963 
DayDay2  -0.162130 0.153353 -1.131 0.2908 
Analyte 1.000111 0.002210 452.496 <2e-16*** 
DayDay2:Analyte 0.006439 0.003126 2.060  
     
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error:  0.2015 on 8 degrees of freedom 
Multiple R-squared:   1 
Adjusted R-squared:   1 
F-statistic:   1.374e+05 on 3 and 8 DF,   
p-value:  < 2.2e-16 
The model estimated four parameters from the data (four rows): two intercepts and 
two slopes. With only two groups to compare (day 1 and day 2), the t-test is 
sufficient to verify the hypothesis of equal slopes. 
From the results, the hypothesis of equal slope between the regression lines is 
accepted (p-level = 0.0733), with a level of confidence of 95%. 
At this point, it is possible to adopt an additive model which determines the two 
regression lines with the same slope (parallel lines). From this model, it is possible 
to test the hypothesis of equal intercepts: 
> model_2 <- lm(Computed ~ Day + Std, Edata) 




The output is: 
 
Call: 
lm(formula = Computed ~ Day + Std, data = Edata) 
 
Residuals:     
Min 1Q Median 3Q Max 
-0.33685 -0.11951 0.02812 0.03314 0.37376 
 
Coefficients:     
 Estimate Std. Error T value Pr(>|t|) 
(Intercept) -0.030376 0.107667 -0.282 0.784 
DayDay2 0.010450 0.135687 0.077 0.940 
Std     
     
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Residual standard error: 0.235 on 9 degrees of freedom 
Multiple R-squared: 1 
Adjusted R-squared: 1 
F-statistic: 1.514e+05 on 2 and 9 DF, 
p-value: < 2.2e-16 
 
From the output, the p-value for the coefficient Day2 is 0.940 and therefore the null 
hypothesis of equal intercepts between the two regression lines is accepted.  
Finally, the two calibration curves derived from the analysis of Estrone in surface 
water in two different days can be assumed coincident at a level of confidence of 
95%.  
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The same results can be obtained by a summary R command which results in an 
ANOVA table with the following parameters. 
> model_B<-aov(Computed~Std*Day, Edata) 
> summary(model_B) 
 
 Df Sum Sq Mean Sq F value Pr(>F) 
Std. 1 16732 16732 4.121e-05 <2e-16*** 
Day 1 0 0 8.000e-3 0.9306 
Std:Day 1 0 0 4.244e+0 0.0733 
Residual 8 0 0   
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
As in the case a, the F and probability values for the interaction term (Day x Std) 
and for the intercept (Std) are higher than 0.5, indicating that the hypothesis of 
equal slopes and intercepts is satisfied. 
4.3. Estrone: case c. – Surface vs. MilliQ water 
After separately testing the day-to-day comparability of calibration curves in the 
MilliQ and Surface waters, it is possible to compare the calibration curves between 
the two matrices. In this case, the ANCOVA will give us information on the effect of 
the matrix type. The calibration curve of the first day for each matrix type was 
taken for performing the ANCOVA. 
Since case c is similar to case b, only the summary R command is given. 
> model<-aov(Computed~Std*Day, Edata) 
> summary(model) 
 
 Df Sum Sq Mean Sq F value Pr(>F) 
Std. 1 16716 16716 2.189e+05 <2e-16 
Day 1 0 0 6.8000e-02 0.802 
Std:Day 1 0 0 1.627e+00 0.238 
Residual 8 1 0   
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
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Based on the results, the hypothesis of equal slope between the regression lines is 
accepted (p-level of the interaction term = 0.238) at a 95% level of confidence. 
Moreover, the p-values for the effect of the Day parameter is 0.802, indicating 
equal intercepts between calibration curves. 
Finally, the two calibration curves derived from the analysis of Estrone in surface 
and MilliQ waters can be assumed to be coincident at a level of confidence of 95%. 
This implies that there is no a significant effect of matrix type on calibration curves 
for the considered analyte. 
The procedure described for the Estrone compound was also applied to the 17-
Estradiol compound. Only the summary results are given here. 
4.4. 17-Estradiol case a – MilliQ water 
For case a, the ANOVA summary table is the following: 
> model_B<-aov(Computed~Day*Std, Edata) 
> summary(model_B) 
 
 Df Sum Sq Mean Sq F value Pr(>F) 
Std. 1 51515 51515 61977.448 <2e-16*** 
Day 4 0 0 0.001 1.000 
Std:Day 4 4 1 1.113 0.378 
Residual 20 17 1   
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
The probability for the interaction term (Day:Std) is equal to 0.378, and the 
hypothesis of equal slopes between the five calibration curves is accepted. 
In the case of the intercept (Day parameter), the p-value is 1.0, and even 
intercepts are comparable. Again, this indicates that there is no significant 
difference between the slopes and the intercepts of the calibration curves, at a level 
of confidence of 95%. 
4.5. 17-estradiol case b – Surface water 
From the summary computation, the R output is: 
 
 Df Sum Sq Mean Sq F value Pr(>F) 
Std. 1 20626 20626 3.12e+04 1.18e-15*** 
Day 1 0 0 3.00e-2 0.867 
Std:Day 1 0 0 6.00e-03 0.942 
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Residual 8 5 1   
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
For the interaction term (Day x Std), the probability value P higher is 0.942, 
indicating that there is no significant difference between the slopes of the 
calibration curves. Moreover, the p-values for the effect of the Day parameter is 
0.867, indicating equal intercepts between calibration curves. 
4.6. 17-estradiol case c – Surface vs. MilliQ water 
After separately testing the daily comparability of calibration curves in the MilliQ an
d Surface waters, it is possible to compare the calibration curves between the two 
matrices. The output result is: 
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 Df Sum Sq Mean Sq F value Pr(>F) 
Std. 1 20528 20528 21443.715 5.29e-15*** 
Day 1 0 0 0.006 0.939 
Std:Day 1 0 0 0.169 0.692 
Residual 8 8 1   
Signif. Codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
For the interaction term (Day x Std), the probability value P higher is 0.692, 
indicating that there is no significant difference between the slopes of the 
calibration curves. Moreover, the p-value for the effect of the Day parameter is 
0.939, indicating equal intercepts between calibration curves. This implies that the 
matrix type has no significant effect on calibration curves for the considered 
analyte. 
5. Conclusions 
In conclusion, for Estrone and 17-Estradiol, the calibration curves determined in 
MilliQ and in surface waters are coincident (same slopes and same intercepts). For 
method validation purposes, the absence of a matrix effect over the concentration 
range of interest means than no new method validation needs to be carried out 
when the matrix type changes.  
Finally, the method validated for Estrone and 17-Estradiol in MilliQ water can also 
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